nerolidol has been researched along with Cognition Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldissera, MD; Cossetin, LF; da Rocha, MI; da Silva, AP; da Silva, AS; da Veiga, ML; Grando, TH; Monteiro, SG; Moreira, KL; Schafer, AS; Souza, CF; Stefani, LM | 1 |
1 other study(ies) available for nerolidol and Cognition Disorders
Article | Year |
---|---|
Nerolidol-loaded nanospheres prevent behavioral impairment via ameliorating Na
Topics: Acetylcholinesterase; Animals; Antioxidants; Avoidance Learning; Behavior, Animal; Brain; Catalase; Central Nervous System Protozoal Infections; Cholinesterase Inhibitors; Cognition Disorders; Disease Models, Animal; Female; GPI-Linked Proteins; Memory; Memory Disorders; Mice; Motor Activity; Nanospheres; Nootropic Agents; Oxidative Stress; Reaction Time; Reactive Oxygen Species; Sesquiterpenes; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Trypanosoma; Trypanosomiasis | 2017 |